E Harvey Estes1, Zhu-Ming Zhang2, Yabing Li2, Larisa G Tereschenko3, Elsayed Z Soliman4. 1. Department of Community and Family Medicine, Duke University Medical Center, Durham, NC. Electronic address: harveyestes@me.com. 2. Epidemiological Cardiology Research Center, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC. 3. Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR. 4. Epidemiological Cardiology Research Center, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC; Department of Medicine, Section on Cardiology, Wake Forest School of Medicine, Winston-Salem, NC.
Abstract
BACKGROUND: The same electrocardiographic (ECG) criteria that have been used for detection of left ventricular hypertrophy (LVH) have recently been recognized as predictors of adverse clinical outcomes, but this predictive ability is inadequately explored and understood. METHODS: A total of 14,984 participants from the ARIC study were included in this analysis. Romhilt-Estes (R-E) LVH score was measured from the automatically processed baseline (1987-1989) ECG data. All-cause mortality was ascertained up to December 2010. Cox proportional hazard models were used to examine the association between baseline R-E score, overall and each of its 6 individual components separately, with all-cause mortality. The associations between change in R-E score between baseline and first follow-up visit with mortality were also examined. RESULTS: During a median follow-up of 21.7 years, 4,549 all-cause mortality events occurred during follow-up. In multivariable-adjusted models, increasing levels of the R-E score was associated with increasing risk of mortality both as a baseline finding and as a change between the baseline and the first follow-up visit. Of the 6 ECG components of the score, 4 were predictive of all-cause mortality (P-terminal force, QRS amplitude, LV strain, and intrinsicoid deflection), whereas 2 of the components were not (left axis deviation and prolonged QRS duration). Differences in the strengths of the associations between the individual components of the score and mortality were observed. CONCLUSIONS: The R-E score, traditionally used for detection of LVH, could be used as a useful tool for predication of adverse outcomes.
BACKGROUND: The same electrocardiographic (ECG) criteria that have been used for detection of left ventricular hypertrophy (LVH) have recently been recognized as predictors of adverse clinical outcomes, but this predictive ability is inadequately explored and understood. METHODS: A total of 14,984 participants from the ARIC study were included in this analysis. Romhilt-Estes (R-E) LVH score was measured from the automatically processed baseline (1987-1989) ECG data. All-cause mortality was ascertained up to December 2010. Cox proportional hazard models were used to examine the association between baseline R-E score, overall and each of its 6 individual components separately, with all-cause mortality. The associations between change in R-E score between baseline and first follow-up visit with mortality were also examined. RESULTS: During a median follow-up of 21.7 years, 4,549 all-cause mortality events occurred during follow-up. In multivariable-adjusted models, increasing levels of the R-E score was associated with increasing risk of mortality both as a baseline finding and as a change between the baseline and the first follow-up visit. Of the 6 ECG components of the score, 4 were predictive of all-cause mortality (P-terminal force, QRS amplitude, LV strain, and intrinsicoid deflection), whereas 2 of the components were not (left axis deviation and prolonged QRS duration). Differences in the strengths of the associations between the individual components of the score and mortality were observed. CONCLUSIONS: The R-E score, traditionally used for detection of LVH, could be used as a useful tool for predication of adverse outcomes.
Authors: Edward P Havranek; Desiree B Froshaug; Caroline D B Emserman; Rebecca Hanratty; Mori J Krantz; Frederick A Masoudi; L Miriam Dickinson; John F Steiner Journal: Am J Med Date: 2008-10 Impact factor: 4.965
Authors: P M Okin; R B Devereux; J E Liu; L Oikarinen; S Jern; S E Kjeldsen; S Julius; K Wachtell; M S Nieminen; B Dahlöf Journal: J Hum Hypertens Date: 2004-06 Impact factor: 3.012
Authors: Ljuba Bacharova; Haiying Chen; E Harvey Estes; Anton Mateasik; David A Bluemke; Joao A C Lima; Gregory L Burke; Elsayed Z Soliman Journal: Am J Cardiol Date: 2014-11-29 Impact factor: 2.778
Authors: Dragan B Djordjevic; Ivan S Tasic; Svetlana T Kostic; Bojana N Stamenkovic; Milan B Lovic; Nikola D Djordjevic; Goran P Koracevic; Dragan B Lovic Journal: Clin Cardiol Date: 2020-06-03 Impact factor: 2.882
Authors: Jan Szewieczek; Zbigniew Gąsior; Jan Duława; Tomasz Francuz; Katarzyna Legierska; Agnieszka Batko-Szwaczka; Beata Hornik; Magdalena Janusz-Jenczeń; Iwona Włodarczyk; Krzysztof Wilczyński Journal: Age (Dordr) Date: 2016-04-02